Europska Unija - hrvatski - EMA (European Medicines Agency)

biogen netherlands b.v. - nusinersen natrij - mišićna atrofija, kralješnica - ostali lijekovi protiv živčanog sustava - spinraza je indicirana za liječenje 5q spinalne mišićne atrofije.

Europska Unija - hrvatski - EMA (European Medicines Agency)

recordati netherlands b.v. - tivozanib - karcinom, stanice bubrega - antineoplastična sredstva - fotivda je indiciran za prvu liniju liječenja odraslih bolesnika s uznapredovalim karcinomom bubrežnih stanica (rcc) i u odraslih bolesnika koji su vegfr i mtor put inhibitora-naivni nakon progresije bolesti nakon jedno liječenje citokina terapija za uznapredovali. liječenje najčešći почечно-stanica karcinoma.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

atnahs pharma netherlands b.v., orestads boulevard 108, 5.tv, kobenhavn s, danska - kalcitriol - kapsula, meka - 0,25 mikrograma - urbroj: svaka meka kapsula sadrži 0,25 mikrograma kalcitriola

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

atnahs pharma netherlands b.v., orestads boulevard 108, 5.tv, kobenhavn s, danska - kalcitriol - kapsula, meka - 0,5 mikrograma - urbroj: svaka meka kapsula sadrži 0,5 mikrograma kalcitriola

Europska Unija - hrvatski - EMA (European Medicines Agency)

gilead sciences ireland uc - bictegravir, эмтрицитабин, Тенофовир alafenamide, фумарат - hiv infekcije - antivirusni lijekovi za sustavnu uporabu - biktarvy is indicated for the treatment of human immunodeficiency virus 1 (hiv 1) infection in adults and paediatric patients at least 2 years of age and weighing at least 14 kg i without present or past evidence of viral resistance to the integrase inhibitor class, emtricitabine or tenofovir. (vidi odjeljak 5.

Europska Unija - hrvatski - EMA (European Medicines Agency)

alnylam netherlands b.v. - patisiran natrija - Амилоидоз, obiteljska - ostali lijekovi protiv živčanog sustava - onpattro indiciran za liječenje nasljednih транстиретина-посредничанного амилоидоза (hattr амилоидоз) u odraslih bolesnika s fazi 1 ili 2 fazi полинейропатии.

Europska Unija - hrvatski - EMA (European Medicines Agency)

otsuka pharmaceutical netherlands b.v. - brexpiprazole - shizofrenija - psycholeptics - liječenje shizofrenije.

Europska Unija - hrvatski - EMA (European Medicines Agency)

eli lilly nederland b.v. - abemaciclib - neoplazme dojki - antineoplastična sredstva - early breast cancerverzenios in combination with endocrine therapy is indicated for the adjuvant treatment of adult patients with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative, node positive early breast cancer at high risk of recurrence (see section 5. in pre or perimenopausal women, aromatase inhibitor endocrine therapy should be combined with a luteinising hormone-releasing hormone (lhrh) agonist. advanced or metastatic breast cancerverzenios is indicated for the treatment of women with hormone receptor (hr) positive, human epidermal growth factor receptor 2 (her2) negative locally advanced or metastatic breast cancer in combination with an aromatase inhibitor or fulvestrant as initial endocrine-based therapy, or in women who have received prior endocrine therapy. in pre- or perimenopausal women, the endocrine therapy should be combined with a lhrh agonist.

Europska Unija - hrvatski - EMA (European Medicines Agency)

merck sharp & dohme b.v. - doravirine, lamivudin, Тенофовир дизопроксил фумарат - hiv infekcije - antivirusni lijekovi za liječenje hiv infekcija, kombinacija - delstrigo indiciran za liječenje odraslih osoba zaraženih hiv-1, bez prošlosti ili ovih dokaza otpornost do klase ННИОТ, lamivudin ili Тенофовир. delstrigo is also indicated for the treatment of adolescents aged 12 years and older weighing at least 35 kg who are infected with hiv-1 without past or present evidence of resistance to the nnrti class, lamivudine, or tenofovir and who have experienced toxicities which preclude the use of other regimens that do not contain tenofovir disoproxil.

Europska Unija - hrvatski - EMA (European Medicines Agency)

seqirus netherlands b.v. - a/darwin/6/2021(h3n2)-like strain (a/darwin/11/2021, wild type) / a/wisconsin/67/2022 (h1n1)pdm09-like strain (a/georgia/12/2022 cvr-167) / b/austria/1359417/2021-like strain (b/singapore/wuh4618/2021) / b/phuket/3073/2013-like virus (b/singapore/inftt-16-0610/2016, wild type) - gripa, ljudska - virus gripe, инактивированная, split ili površinski antigen - prophylaxis of influenza in adults and children from 2 years of age. flucelvax tetra treba primjenjivati u skladu sa službenim preporukama.